September 2024 Br J Cardiol 2024;31:85–7 doi:10.5837/bjc.2024.039
Raj Thakkar
Professor Raj Thakkar The challenging questions we must ask ourselves are: How and why did we reach this status quo? What are the consequences of continuing to operate in the current care model? What should we do about it, by when and how? Are we really offering true value across the whole patient journey (and if we think we are, how do we know)? Do we honestly look outside our own business or service delivery units? Unified value and operational integration Let’s consider value for a moment. Can the NHS deliver true value-based care unless integrated-care systems (ICSs) are operationally integrated; but how can ICSs integrate if individu
October 2022 Br J Cardiol 2022;29:125–6 doi:10.5837/bjc.2022.031
Rani Khatib
Meeting patient needs Dr Rani Khatib Previously, individuals with CV disease and type 2 diabetes in our area were treated by two separate specialty teams. However, it is now well-established that there is significant interplay between CV and metabolic disease, as well as renal disorders.2,3 Thus, we have come to believe that the management of complex post-MI Cardio–Renal–Metabolic or ‘CaReMe’ cases requires a more holistic care model. In this way, we can ensure that patients gain easy access to all required risk and medicine optimisation, and other forms of care, in line with current treatment guidelines, and individually tailored to
You need to be a member to print this page.
Find out more about our membership benefits
You need to be a member to download PDF's.
Find out more about our membership benefits